Rivian Releases First Quarter 2026 Financial Results
- Started production of saleable R2 vehicles and made first deliveries to employees with external customer deliveries expected in the coming weeks
-
Consolidated revenue growth of 11 percent year-over-year and generated
$119 million of consolidated gross profit for the quarter -
Increased
Georgia plant initial production capacity to 300,000 vehicles annually; expects first advance on$4.5 billion DOE loan in early 2027 - Robotaxi partnership with Uber to deploy up to 50,000 fully autonomous robotaxis
-
$1 billion of funding from Volkswagen Group through successful completion of winter testing
RJ Scaringe, Rivian Founder and CEO, said:
“With the launch of R2, we are excited to dramatically expand our market opportunity and have more people driving Rivians. The support of the
Business Highlights
Last week
The company made the strategic decision to increase the initial production capacity of its
As part of this new vision for the
In March,
Last month, Rivian’s joint venture with Volkswagen Group,
First Quarter 2026 Results Summary
Production and Deliveries
-
10,236 vehicles produced at Rivian’s manufacturing facility in
Normal, Illinois . - 10,365 vehicles delivered to customers.
Revenues
-
Consolidated revenue was
$1,381 million , an 11 percent increase over the same quarter of the previous year.-
Automotive segment revenue was
$908 million , a 2 percent decrease over the same quarter of the previous year, primarily due to a$100 million decrease in sales of automotive regulatory credits and a decline in automotive revenue per unit delivered due to a higher mix of commercial vans, which were partially offset by a 20 percent increase in vehicle deliveries. -
Software and services segment revenue was
$473 million , a 49 percent increase over the same quarter of the previous year, due to an increase in vehicle electrical architecture and software development services, as well as vehicle repair and maintenance service and remarketing.
-
Automotive segment revenue was
Gross Profit
-
Consolidated gross profit was
$119 million , an$87 million decrease over the same quarter in the previous year.-
Automotive segment gross profit loss was
$(62) million compared to$92 million in gross profit for the same quarter in 2025, due primarily to the$100 million decrease in sales of automotive regulatory credits and lower production volumes, resulting in a$42 million and$3 million increase in depreciation and stock based compensation respectively. -
Software and services segment gross profit was
$181 million , a$67 million increase over the same quarter of the previous year, primarily due to higher vehicle electrical architecture and software development services and vehicle repair and maintenance services.
-
Automotive segment gross profit loss was
Operating Expenses and Operating Loss
-
Total operating expenses in the first quarter increased to
$1,000 million , compared to$861 million in the same quarter of the previous year. Within operating expenses, we recognized non-cash, stock-based compensation expenses of$180 million compared to$159 million in the same quarter of the previous year and depreciation and amortization expense of$80 million as compared to$72 million in the same quarter of the previous year.-
Research and development (R&D) expense was
$458 million compared to$381 million in the same quarter of the previous year. The increase was primarily related to increased software and cloud spend on autonomy and R2 pre-production costs, including payroll and related expenses. -
Selling, general and administrative (SG&A) expense was
$542 million compared to$480 million in the same quarter the previous year. The increase was primarily related to expanding our go-to-market operations and footprint, including higher payroll and stock-based compensation expenses and facilities, software, and other operating expenses.
-
Research and development (R&D) expense was
-
For the first quarter of 2026, we experienced a loss from operations of
$881 million compared to$655 million in the same quarter of the previous year due to lower gross profit and higher operating expenses.
Adjusted Operating Expenses
-
Total adjusted operating expenses for the first quarter of 2026 were
$740 million compared to$630 million for the same quarter of the previous year.-
Adjusted R&D expenses for the first quarter of 2026 were
$348 million compared to$285 million for the same quarter the previous year. -
Adjusted SG&A expenses for the first quarter of 2026 were
$392 million compared to$345 million for the same quarter the previous year.
-
Adjusted R&D expenses for the first quarter of 2026 were
Net Loss
-
Net loss for the first quarter of 2026 was
$(416) million compared to$(541) million for the same quarter the previous year. Net loss for the quarter benefited from a$506 million gain in other income related to the Series A capital raise and related deconsolidation of Mind Robotics.
Adjusted EBITDA
-
Adjusted EBITDA for the first quarter of 2026 was
$(472) million compared to$(329) million for the same quarter the previous year.
-
Net cash used in operating activities for the first quarter of 2026 was
$(703) million compared to$(188) million for the same quarter the previous year. The increase in net cash used in operations was primarily driven by cash consumed by working capital, increased operating expenses, and a reduction in regulatory credit sales.
Capital Expenditures
-
Capital expenditures for the first quarter of 2026 were
$372 million compared to$338 million for the same quarter the previous year.
Liquidity and Free Cash Flow
-
Rivian ended the first quarter of 2026 with$4,830 million in cash, cash equivalents, and short-term investments.-
Including the capacity under our asset-based revolving-credit facility, we ended the first quarter of 2026 with
$5,394 million of total liquidity.
-
Including the capacity under our asset-based revolving-credit facility, we ended the first quarter of 2026 with
-
We define free cash flow as net cash used or provided by operating activities less capital expenditures. The increase in net cash used in operating activities coupled with the increase in capital expenditures discussed above resulted in negative free cash flow¹ of
$(1,075) million for the first quarter of 2026 compared to negative free cash flow of$(526) million for the same quarter the previous year.
2026 Annual Guidance Summary
|
|
Current Outlook |
|
Vehicles Delivered |
62,000 - 67,000 |
|
Adjusted EBITDA |
|
|
Capital Expenditures |
|
Q1 2026 Results Webcast and Replay Information
|
Quarterly Financial Performance (in millions, except production, delivery, and gross margin) (unaudited) |
||||||||||||||||||||
|
|
|
Three Months Ended |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Production |
|
|
14,611 |
|
|
|
5,979 |
|
|
|
10,720 |
|
|
|
10,974 |
|
|
|
10,236 |
|
|
Delivery |
|
|
8,640 |
|
|
|
10,661 |
|
|
|
13,201 |
|
|
|
9,745 |
|
|
|
10,365 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Automotive |
|
$ |
922 |
|
|
$ |
927 |
|
|
$ |
1,142 |
|
|
$ |
839 |
|
|
$ |
908 |
|
|
Software and services |
|
|
318 |
|
|
|
376 |
|
|
|
416 |
|
|
|
447 |
|
|
|
473 |
|
|
Total revenues |
|
$ |
1,240 |
|
|
$ |
1,303 |
|
|
$ |
1,558 |
|
|
$ |
1,286 |
|
|
$ |
1,381 |
|
|
Cost of revenues |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Automotive |
|
$ |
830 |
|
|
$ |
1,262 |
|
|
$ |
1,272 |
|
|
$ |
898 |
|
|
$ |
970 |
|
|
Software and services |
|
|
204 |
|
|
|
247 |
|
|
|
262 |
|
|
|
268 |
|
|
|
292 |
|
|
Total cost of revenues |
|
$ |
1,034 |
|
|
$ |
1,509 |
|
|
$ |
1,534 |
|
|
$ |
1,166 |
|
|
$ |
1,262 |
|
|
Gross profit |
|
$ |
206 |
|
|
$ |
(206 |
) |
|
$ |
24 |
|
|
$ |
120 |
|
|
$ |
119 |
|
|
Gross margin |
|
|
17 |
% |
|
|
(16 |
)% |
|
|
2 |
% |
|
|
9 |
% |
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Research and development |
|
$ |
381 |
|
|
$ |
410 |
|
|
$ |
453 |
|
|
$ |
424 |
|
|
$ |
458 |
|
|
Selling, general, and administrative |
|
|
480 |
|
|
|
498 |
|
|
|
554 |
|
|
|
529 |
|
|
|
542 |
|
|
Total operating expenses |
|
$ |
861 |
|
|
$ |
908 |
|
|
$ |
1,007 |
|
|
$ |
953 |
|
|
$ |
1,000 |
|
|
Adjusted research and development (non-GAAP)¹ |
|
$ |
285 |
|
|
$ |
316 |
|
|
$ |
361 |
|
|
$ |
328 |
|
|
$ |
348 |
|
|
Adjusted selling, general, and administrative (non-GAAP)¹ |
|
|
345 |
|
|
|
365 |
|
|
|
422 |
|
|
|
384 |
|
|
|
392 |
|
|
Total adjusted operating expenses (non-GAAP)¹ |
|
$ |
630 |
|
|
$ |
681 |
|
|
$ |
783 |
|
|
$ |
712 |
|
|
$ |
740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Adjusted EBITDA (non-GAAP)1 |
|
$ |
(329 |
) |
|
$ |
(667 |
) |
|
$ |
(602 |
) |
|
$ |
(465 |
) |
|
$ |
(472 |
) |
|
Cash, cash equivalents, and short-term investments |
|
$ |
7,178 |
|
|
$ |
7,508 |
|
|
$ |
7,088 |
|
|
$ |
6,082 |
|
|
$ |
4,830 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net cash (used)/provided by operating activities |
|
$ |
(188 |
) |
|
$ |
64 |
|
|
$ |
26 |
|
|
$ |
(681 |
) |
|
$ |
(703 |
) |
|
Capital expenditures |
|
|
(338 |
) |
|
|
(462 |
) |
|
|
(447 |
) |
|
|
(463 |
) |
|
|
(372 |
) |
|
Free cash flow (non-GAAP)¹ |
|
$ |
(526 |
) |
|
$ |
(398 |
) |
|
$ |
(421 |
) |
|
$ |
(1,144 |
) |
|
$ |
(1,075 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Depreciation and amortization expense |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cost of revenues |
|
$ |
75 |
|
|
$ |
185 |
|
|
$ |
125 |
|
|
$ |
108 |
|
|
$ |
122 |
|
|
Research and development |
|
|
17 |
|
|
|
17 |
|
|
|
18 |
|
|
|
20 |
|
|
|
23 |
|
|
Selling, general, and administrative |
|
|
55 |
|
|
|
52 |
|
|
|
55 |
|
|
|
59 |
|
|
|
57 |
|
|
Total depreciation and amortization expense |
|
$ |
147 |
|
|
$ |
254 |
|
|
$ |
198 |
|
|
$ |
187 |
|
|
$ |
202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cost of revenues |
|
$ |
24 |
|
|
$ |
37 |
|
|
$ |
24 |
|
|
$ |
26 |
|
|
$ |
27 |
|
|
Research and development |
|
|
79 |
|
|
|
77 |
|
|
|
74 |
|
|
|
76 |
|
|
|
87 |
|
|
Selling, general, and administrative |
|
|
80 |
|
|
|
81 |
|
|
|
77 |
|
|
|
86 |
|
|
|
93 |
|
|
Total stock-based compensation expense |
|
$ |
183 |
|
|
$ |
195 |
|
|
$ |
175 |
|
|
$ |
188 |
|
|
$ |
207 |
|
|
¹A reconciliation of non-GAAP financial measures to the most comparable GAAP measure is provided later in this presentation. |
||||||||||||||||||||
|
Condensed Consolidated Balance Sheets 1 (in millions, except per share amounts) (unaudited) |
||||||||
|
Assets |
|
|
|
|
||||
|
Current assets: |
|
|
|
|
||||
|
Cash and cash equivalents |
|
$ |
3,579 |
|
|
$ |
2,845 |
|
|
Short-term investments |
|
|
2,503 |
|
|
|
1,985 |
|
|
Accounts receivable, net |
|
|
555 |
|
|
|
342 |
|
|
Inventory |
|
|
1,594 |
|
|
|
1,543 |
|
|
Other current assets |
|
|
361 |
|
|
|
330 |
|
|
Total current assets |
|
|
8,592 |
|
|
|
7,045 |
|
|
Property, plant, and equipment, net |
|
|
5,119 |
|
|
|
5,434 |
|
|
Operating lease assets, net |
|
|
571 |
|
|
|
601 |
|
|
Strategic investments |
|
|
119 |
|
|
|
669 |
|
|
Other non-current assets |
|
|
463 |
|
|
|
484 |
|
|
Total assets |
|
$ |
14,864 |
|
|
$ |
14,233 |
|
|
|
|
|
|
|
||||
|
Liabilities and Stockholders’ Equity |
|
|
|
|
||||
|
Current liabilities: |
|
|
|
|
||||
|
Accounts payable |
|
$ |
595 |
|
|
$ |
754 |
|
|
Accrued liabilities |
|
|
1,438 |
|
|
|
1,045 |
|
|
Current portion of deferred revenues, lease liabilities, and other liabilities |
|
|
1,660 |
|
|
|
1,554 |
|
|
Total current liabilities |
|
|
3,693 |
|
|
|
3,353 |
|
|
Long-term debt |
|
|
4,440 |
|
|
|
4,442 |
|
|
Non-current lease liabilities |
|
|
551 |
|
|
|
580 |
|
|
Other non-current liabilities |
|
|
1,586 |
|
|
|
1,429 |
|
|
Total liabilities |
|
|
10,270 |
|
|
|
9,804 |
|
|
Commitments and contingencies |
|
|
|
|
||||
|
Stockholders' equity: |
|
|
|
|
||||
|
Preferred stock, |
|
|
— |
|
|
|
— |
|
|
Common stock, |
|
|
1 |
|
|
|
1 |
|
|
Additional paid-in capital |
|
|
31,508 |
|
|
|
31,767 |
|
|
Accumulated deficit |
|
|
(26,951 |
) |
|
|
(27,367 |
) |
|
Accumulated other comprehensive income |
|
|
8 |
|
|
|
2 |
|
|
Noncontrolling interest |
|
|
28 |
|
|
|
26 |
|
|
Total stockholders' equity |
|
|
4,594 |
|
|
|
4,429 |
|
|
|
|
|
|
|
||||
|
Total liabilities and stockholders' equity |
|
$ |
14,864 |
|
|
$ |
14,233 |
|
|
1 The prior period has been recast to conform to current period presentation. |
|
|
|
|
||||
|
Condensed Consolidated Statements of Operations (in millions, except per share amounts) (unaudited) |
||||||||
|
|
|
Three Months Ended |
||||||
|
|
|
|
2025 |
|
|
|
2026 |
|
|
Automotive |
|
$ |
922 |
|
|
$ |
908 |
|
|
Software and services |
|
|
318 |
|
|
|
473 |
|
|
Total revenues |
|
|
1,240 |
|
|
|
1,381 |
|
|
Automotive |
|
|
830 |
|
|
|
970 |
|
|
Software and services |
|
|
204 |
|
|
|
292 |
|
|
Total cost of revenues |
|
|
1,034 |
|
|
|
1,262 |
|
|
Gross profit |
|
|
206 |
|
|
|
119 |
|
|
Operating expenses |
|
|
|
|
||||
|
Research and development |
|
|
381 |
|
|
|
458 |
|
|
Selling, general, and administrative |
|
|
480 |
|
|
|
542 |
|
|
Total operating expenses |
|
|
861 |
|
|
|
1,000 |
|
|
Loss from operations |
|
|
(655 |
) |
|
|
(881 |
) |
|
Interest income |
|
|
81 |
|
|
|
50 |
|
|
Interest expense |
|
|
(72 |
) |
|
|
(65 |
) |
|
Other income, net1 |
|
|
107 |
|
|
|
478 |
|
|
Loss before income taxes |
|
|
(539 |
) |
|
|
(418 |
) |
|
Provision for income taxes |
|
|
(2 |
) |
|
|
2 |
|
|
Net loss |
|
|
(541 |
) |
|
|
(416 |
) |
|
Less: Net income attributable to noncontrolling interest |
|
|
4 |
|
|
|
— |
|
|
Net loss attributable to common stockholders |
|
$ |
(545 |
) |
|
$ |
(416 |
) |
|
Net loss attributable to common stockholders, basic and diluted |
|
$ |
(545 |
) |
|
$ |
(416 |
) |
|
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted |
|
$ |
(0.48 |
) |
|
$ |
(0.33 |
) |
|
Weighted-average common shares outstanding, basic and diluted |
|
|
1,137 |
|
|
|
1,249 |
|
|
1 During the quarter ended |
||||||||
|
Condensed Consolidated Statements of Cash Flows 1 (in millions) (unaudited) |
||||||||
|
|
|
Three Months Ended |
||||||
|
|
|
|
2025 |
|
|
|
2026 |
|
|
Cash flows from operating activities: |
|
|
|
|
||||
|
Net loss |
|
$ |
(541 |
) |
|
$ |
(416 |
) |
|
Depreciation and amortization |
|
|
200 |
|
|
|
194 |
|
|
Stock-based compensation expense |
|
|
188 |
|
|
|
207 |
|
|
Gain on strategic investments |
|
|
(101 |
) |
|
|
(506 |
) |
|
Other non-cash activities |
|
|
20 |
|
|
|
74 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
||||
|
Accounts receivable, net |
|
|
31 |
|
|
|
211 |
|
|
Inventory |
|
|
(364 |
) |
|
|
(80 |
) |
|
Other assets |
|
|
14 |
|
|
|
89 |
|
|
Accounts payable and accrued liabilities |
|
|
334 |
|
|
|
(182 |
) |
|
Deferred revenues |
|
|
59 |
|
|
|
(290 |
) |
|
Other liabilities |
|
|
(28 |
) |
|
|
(4 |
) |
|
Net cash used in operating activities |
|
|
(188 |
) |
|
|
(703 |
) |
|
|
|
|
|
|
||||
|
Cash flows from investing activities: |
|
|
|
|
||||
|
Purchases of equity securities and short-term investments |
|
|
(835 |
) |
|
|
(558 |
) |
|
Sales of equity securities and short-term investments |
|
|
48 |
|
|
|
16 |
|
|
Maturities of short-term investments |
|
|
717 |
|
|
|
1,003 |
|
|
Deconsolidation of |
|
|
— |
|
|
|
(114 |
) |
|
Capital expenditures |
|
|
(338 |
) |
|
|
(372 |
) |
|
Net cash used in investing activities |
|
|
(408 |
) |
|
|
(25 |
) |
|
|
|
|
|
|
||||
|
Cash flows from financing activities: |
|
|
|
|
||||
|
Proceeds from stock-based compensation programs |
|
|
2 |
|
|
|
1 |
|
|
Other financing activities |
|
|
(8 |
) |
|
|
(3 |
) |
|
Net cash used in financing activities |
|
|
(6 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
||||
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
1 |
|
|
|
(4 |
) |
|
Net change in cash |
|
|
(601 |
) |
|
|
(734 |
) |
|
Cash, cash equivalents, and restricted cash—Beginning of period |
|
|
5,294 |
|
|
|
3,579 |
|
|
Cash, cash equivalents, and restricted cash—End of period |
|
$ |
4,693 |
|
|
$ |
2,845 |
|
|
|
|
|
|
|
||||
|
Supplemental disclosure of non-cash investing and financing activities: |
|
|
|
|
||||
|
Capital expenditures included in liabilities |
|
$ |
423 |
|
|
$ |
534 |
|
|
Capital stock issued to settle bonuses |
|
$ |
47 |
|
|
$ |
110 |
|
|
Right-of-use assets obtained in exchange for operating lease liabilities |
|
$ |
73 |
|
|
$ |
60 |
|
|
1 The prior period has been recast to conform to current period presentation. |
||||||||
|
|
||||||||
|
Reconciliation of Non-GAAP Financial Measures (in millions) (unaudited) |
||||||||||||||||||||
|
|
|
Three Months Ended |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total research and development expenses |
|
$ |
381 |
|
|
$ |
410 |
|
|
$ |
453 |
|
|
$ |
424 |
|
|
$ |
458 |
|
|
R&D depreciation and amortization expenses |
|
|
(17 |
) |
|
|
(17 |
) |
|
|
(18 |
) |
|
|
(20 |
) |
|
|
(23 |
) |
|
R&D stock-based compensation expenses |
|
|
(79 |
) |
|
|
(77 |
) |
|
|
(74 |
) |
|
|
(76 |
) |
|
|
(87 |
) |
|
Adjusted research and development (non-GAAP) |
|
$ |
285 |
|
|
$ |
316 |
|
|
$ |
361 |
|
|
$ |
328 |
|
|
$ |
348 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Adjusted Selling, General, and Administrative Expenses |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total selling, general, and administrative expenses |
|
$ |
480 |
|
|
$ |
498 |
|
|
$ |
554 |
|
|
$ |
529 |
|
|
$ |
542 |
|
|
SG&A depreciation and amortization expenses |
|
|
(55 |
) |
|
|
(52 |
) |
|
|
(55 |
) |
|
|
(59 |
) |
|
|
(57 |
) |
|
SG&A stock-based compensation expenses |
|
|
(80 |
) |
|
|
(81 |
) |
|
|
(77 |
) |
|
|
(86 |
) |
|
|
(93 |
) |
|
Adjusted selling, general, and administrative (non-GAAP) |
|
$ |
345 |
|
|
$ |
365 |
|
|
$ |
422 |
|
|
$ |
384 |
|
|
$ |
392 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Adjusted Operating Expenses |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total operating expenses |
|
$ |
861 |
|
|
$ |
908 |
|
|
$ |
1,007 |
|
|
$ |
953 |
|
|
$ |
1,000 |
|
|
R&D depreciation and amortization expenses |
|
|
(17 |
) |
|
|
(17 |
) |
|
|
(18 |
) |
|
|
(20 |
) |
|
|
(23 |
) |
|
R&D stock-based compensation expenses |
|
|
(79 |
) |
|
|
(77 |
) |
|
|
(74 |
) |
|
|
(76 |
) |
|
|
(87 |
) |
|
SG&A depreciation and amortization expenses |
|
|
(55 |
) |
|
|
(52 |
) |
|
|
(55 |
) |
|
|
(59 |
) |
|
|
(57 |
) |
|
SG&A stock-based compensation expenses |
|
|
(80 |
) |
|
|
(81 |
) |
|
|
(77 |
) |
|
|
(86 |
) |
|
|
(93 |
) |
|
Total adjusted operating expenses (non-GAAP) |
|
$ |
630 |
|
|
$ |
681 |
|
|
$ |
783 |
|
|
$ |
712 |
|
|
$ |
740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net loss attributable to common stockholders |
|
$ |
(545 |
) |
|
$ |
(1,117 |
) |
|
$ |
(1,173 |
) |
|
$ |
(811 |
) |
|
$ |
(416 |
) |
|
Interest income, net |
|
|
(9 |
) |
|
|
(3 |
) |
|
|
(7 |
) |
|
|
— |
|
|
|
15 |
|
|
Provision for income taxes |
|
|
2 |
|
|
|
2 |
|
|
|
(1 |
) |
|
|
3 |
|
|
|
(2 |
) |
|
Depreciation and amortization |
|
|
147 |
|
|
|
254 |
|
|
|
198 |
|
|
|
187 |
|
|
|
202 |
|
|
Stock-based compensation expense |
|
|
183 |
|
|
|
195 |
|
|
|
175 |
|
|
|
188 |
|
|
|
207 |
|
|
Other (income) expense, net1 |
|
|
(107 |
) |
|
|
2 |
|
|
|
191 |
|
|
|
(32 |
) |
|
|
(478 |
) |
|
Restructuring expenses |
|
|
— |
|
|
|
— |
|
|
|
15 |
|
|
|
— |
|
|
|
— |
|
|
Adjusted EBITDA (non-GAAP) |
|
$ |
(329 |
) |
|
$ |
(667 |
) |
|
$ |
(602 |
) |
|
$ |
(465 |
) |
|
$ |
(472 |
) |
|
1 During the quarter ended |
||||||||||||||||||||
|
Quarterly Financial Performance Reconciliation of Non-GAAP Financial Measures Continued (in millions) (unaudited) |
||||||||||||||||||||
|
|
|
Three Months Ended |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Free Cash Flow |
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net cash (used)/provided by operating activities |
|
|
(188 |
) |
|
|
64 |
|
|
|
26 |
|
|
|
(681 |
) |
|
|
(703 |
) |
|
Capital expenditures |
|
|
(338 |
) |
|
|
(462 |
) |
|
|
(447 |
) |
|
|
(463 |
) |
|
|
(372 |
) |
|
Free cash flow (non-GAAP) |
|
$ |
(526 |
) |
|
$ |
(398 |
) |
|
$ |
(421 |
) |
|
$ |
(1,144 |
) |
|
$ |
(1,075 |
) |
Forward Looking Statements:
This press release and statements that are made on our earnings call contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release and made on our earnings call that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our future operations, initiatives and business strategy, including our future financial results, vehicle profitability and future gross profits, our future capital expenditures, the underlying trends in our business (including customer preferences and expectation), macroeconomic and policy conditions, including changes to the availability of government and economic incentives, including tax credits, for electric vehicles, our market opportunity, and our potential for growth, our production ramp and manufacturing capacity expansion and anticipated production levels, the timeline for the start of production at the
*Non-GAAP Financial Measures
In addition to our results determined in accordance with generally accepted accounting principles in
Our non-GAAP financial measures include adjusted research and development expenses, adjusted selling, general, and administrative expenses, adjusted EBITDA, and free cash flow.
Adjusted research and development expenses is defined as total research and development expenses, less R&D depreciation and amortization expenses and R&D stock-based compensation expenses.
Adjusted selling, general, and administrative expenses is defined as total selling, general, and administrative expenses, less SG&A depreciation and amortization expenses and SG&A stock-based compensation expenses.
Adjusted EBITDA defined as net loss before interest expense (income), net, provision for income taxes, depreciation and amortization, stock-based compensation, other (expense) income, net, and special items. Our management team ordinarily excludes special items from its review of the results of the ongoing operations. Special items is comprised of (i) cost of revenue efficiency initiatives which include costs incurred as we transition between major vehicle programs, cost incurred for negotiations with major suppliers regarding changing demand forecasts or design modifications, and other costs for enhancing capital and cost optimization of the Company (ii) restructuring expenses for significant actions taken by the Company, (iii) significant asset impairments and write-offs, and (iv) other items that we do not necessarily consider to be indicative of earnings from ongoing operating activities, including loss (gain) on convertible note, net, and joint venture formation expenses.
Free cash flow is defined as net cash used in operating activities less capital expenditures.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20260430946068/en/
Investors: ir@rivian.com
Media:
Source: